Summary
HCA Healthcare, Inc. (HCA) reported a strong second quarter and first half of 2018, demonstrating robust revenue growth and improved profitability. Revenues increased by 7.4% for the quarter and 7.5% for the six-month period, driven by a combination of higher patient volumes (equivalent admissions) and increased revenue per equivalent admission. Net income attributable to HCA Healthcare, Inc. saw a significant jump of 24.9% for the quarter and 49.3% for the six months, reflecting improved operational performance and the positive impact of tax reform. The company's operational metrics, such as admissions, surgeries, and emergency department visits, showed positive trends, indicating healthy demand for its services. Despite an increase in operating expenses, particularly salaries and benefits, HCA managed to improve its profit margins. The company also continued its capital allocation strategy through share repurchases and dividend payments, signaling confidence in its financial health and future prospects. The impact of the Tax Cuts and Jobs Act was a notable factor, contributing to lower effective tax rates and increased net income.
Financial Highlights
46 data points| Revenue | $11.53B |
| Operating Expenses | $10.29B |
| Interest Expense | $436.00M |
| Net Income | $820.00M |
| EPS (Basic) | $2.35 |
| EPS (Diluted) | $2.31 |
| Shares Outstanding (Basic) | 348.62M |
| Shares Outstanding (Diluted) | 355.04M |
Key Highlights
- 1Revenues increased by 7.4% to $11.529 billion for Q2 2018 and by 7.5% to $22.952 billion for the six months ended June 30, 2018, compared to the prior year periods.
- 2Net income attributable to HCA Healthcare, Inc. grew by 24.9% to $820 million ($2.31 per diluted share) for Q2 2018 and by 49.3% to $1.964 billion ($5.50 per diluted share) for the first six months of 2018.
- 3Consolidated equivalent admissions increased by 5.1% in Q2 2018, and revenue per equivalent admission grew by 2.1%, indicating strong volume and pricing power.
- 4The effective tax rate decreased significantly due to the 2017 Tax Cuts and Jobs Act, contributing to the substantial increase in net income.
- 5Cash flow from operations increased to $1.582 billion in Q2 2018 and $2.865 billion for the first six months of 2018, demonstrating strong operational cash generation.
- 6The company continued its capital return strategy, repurchasing $893 million of common stock in the first six months of 2018 and declaring a quarterly dividend of $0.35 per share.
- 7Total uncompensated care, a key metric for the healthcare industry, was $817 million for the quarter and $1.592 billion for the six months, showing the company's commitment to providing care regardless of ability to pay.